Molecular and phylogeographic analysis of human immuno-deficiency virus type 1 strains infecting treatment-naive patients from Kigali, Rwanda.
This study aimed at describing the genetic subtype distribution of HIV-1 strains circulating in Kigali and their epidemiological link with the HIV-1 strains from the five countries surrounding Rwanda. One hundred and thirty eight pol (RT and PR) sequences from 116 chronically- and 22 recently-infected antiretroviral therapy (ART)-naïve patients from Kigali were generated and subjected to HIV drug resistance (HIV-DR), phylogenetic and recombinant analyses in connection with 366 reference pol sequences from Rwanda, Burundi, Kenya, Democratic Republic of Congo, Tanzania and Uganda (Los Alamos database). Among the Rwandan samples, subtype A1 predominated (71.7%), followed by A1/C recombinants (18.1%), subtype C (5.8%), subtype D (2.9%), one A1/D recombinant (0.7%) and one unknown subtype (0.7%). Thirteen unique and three multiple A1/C recombinant forms were identified. No evidence for direct transmission events was found within the Rwandan strains. Molecular characteristics of HIV-1 were similar between chronically and recently-infected individuals and were not significantly associated with demographic or social factors. Our report suggests that the HIV-1 epidemic in Kigali is characterized by the emergence of A1/C recombinants and is not phylogenetically connected with the HIV-1 epidemic in the five neighboring countries. The relatively low level of transmitted HIV-DR mutations (2.9%) reported here indicates the good performance of the ART programme in Rwanda. However, the importance of promoting couples' counseling, testing and disclosure during HIV prevention strategies is highlighted.
National Reference Laboratory, Kigali, Rwanda.
John
J
Rusine
Suzanne
S
Jurriaans
Janneke
J
van de Wijgert
Marion
M
Cornelissen
Brenda
B
Kateera
Kimberly
K
Boer
Etienne
E
Karita
Odette
O
Mukabayire
Menno
M
de Jong
Pascale
P
Ondoa
D000328:Adult; D019380:Anti-HIV Agents / Q000494:pharmacology; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D024882:Drug Resistance, Viral / Q000187:drug effects; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000453:epidemiology* / Q000235:genetics* / Q000635:transmission; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008297:Male; D008957:Models, Genetic; D009154:Mutation; D010802:Phylogeny; D058974:Phylogeography; D011995:Recombination, Genetic; D012306:Risk; D012432:Rwanda
D019380:Anti-HIV Agents